Botulinum toxin is a protein that helps stop muscle spasms when it is injected directly into the muscle. Muscle spasms are caused by chemical messages sent to the muscles from nerves. These messages tell the muscles to contract (to tighten up). Botulinum toxin blocks these messages.

The global Botulinum Toxin Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Botulinum Toxin Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Botulinum Toxin Injection market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Botulinum Toxin Injection in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Botulinum Toxin Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
LIBP
Allergan
Ipsen
Medytox
US WorldMeds
Merz
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Medical Type
Cosmetic Type

Segment by Application
Hospital
Clinic
Other